A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe

BACKGROUND: Oral administration of lotilaner flavoured chewable tablets (Credelio™, Elanco) to dogs has been shown to provide a rapid onset of killing activity of infesting ticks, with sustained efficacy for at least 35 days. A study was undertaken in Europe to confirm lotilaner’s safety and anti-ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalleri, Daniela, Murphy, Martin, Seewald, Wolfgang, Drake, Jason, Nanchen, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664821/
https://www.ncbi.nlm.nih.gov/pubmed/29089058
http://dx.doi.org/10.1186/s13071-017-2478-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664821/
https://www.ncbi.nlm.nih.gov/pubmed/29089058
http://dx.doi.org/10.1186/s13071-017-2478-9

Ejemplares similares